Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO) - Ray-Coquard, I; Italiano, A; Bompas, E (Oncologist, 2012)
, et al; French Sarcoma Group (GSF/GETO).